Inter partes review: Benefits for innovators and generic challengers
Dana Lau and Robert S Schwartz of Fitzpatrick Cella Harper & Scinto consider the effects of new inter partes review and supplemental examination procedures in the United States
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
